These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7705382)

  • 41. Niceritrol prevents the decrease in red blood cell 2,3-diphosphoglycerate and neuropathy in streptozotocin-induced diabetic rats.
    Hotta N; Nakamura J; Kakuta H; Fukasawa H; Koh N; Sakakibara F; Mori K; Sakamoto N
    J Diabetes Complications; 1995; 9(3):133-9. PubMed ID: 7548976
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nerve blood flow in early experimental diabetes in rats: relation to conduction deficits.
    Cameron NE; Cotter MA; Low PA
    Am J Physiol; 1991 Jul; 261(1 Pt 1):E1-8. PubMed ID: 1858864
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The neurocytokine, interleukin-6, corrects nerve dysfunction in experimental diabetes.
    Cameron NE; Cotter MA
    Exp Neurol; 2007 Sep; 207(1):23-9. PubMed ID: 17560573
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment with the xanthine oxidase inhibitor, allopurinol, improves nerve and vascular function in diabetic rats.
    Inkster ME; Cotter MA; Cameron NE
    Eur J Pharmacol; 2007 Apr; 561(1-3):63-71. PubMed ID: 17291486
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats.
    Cameron NE; Cotter MA; Maxfield EK
    Diabetologia; 1993 Apr; 36(4):299-304. PubMed ID: 8477873
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits.
    Pop-Busui R; Sullivan KA; Van Huysen C; Bayer L; Cao X; Towns R; Stevens MJ
    Exp Neurol; 2001 Apr; 168(2):259-72. PubMed ID: 11259114
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevention of abnormalities in motor nerve conduction and nerve blood-flow by a prostacyclin analog, beraprost sodium, in streptozotocin-induced diabetic rats.
    Hotta N; Koh N; Sakakibara F; Nakamura J; Hamada Y; Wakao T; Hara T; Mori K; Naruse K; Nakashima W
    Prostaglandins; 1995 Jun; 49(6):339-49. PubMed ID: 7480803
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of protein kinase Cbeta inhibition on neurovascular dysfunction in diabetic rats: interaction with oxidative stress and essential fatty acid dysmetabolism.
    Cameron NE; Cotter MA
    Diabetes Metab Res Rev; 2002; 18(4):315-23. PubMed ID: 12203947
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neurovascular dysfunction in diabetic rats. Potential contribution of autoxidation and free radicals examined using transition metal chelating agents.
    Cameron NE; Cotter MA
    J Clin Invest; 1995 Aug; 96(2):1159-63. PubMed ID: 7635953
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of the sulphydryl donor N-acetyl-L-cysteine on nerve conduction, perfusion, maturation and regeneration following freeze damage in diabetic rats.
    Love A; Cotter MA; Cameron NE
    Eur J Clin Invest; 1996 Aug; 26(8):698-706. PubMed ID: 8872067
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effects of treatment with alpha-lipoic acid or evening primrose oil on vascular hemostatic and lipid risk factors, blood flow, and peripheral nerve conduction in the streptozotocin-diabetic rat.
    Ford I; Cotter MA; Cameron NE; Greaves M
    Metabolism; 2001 Aug; 50(8):868-75. PubMed ID: 11474472
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diabetes mellitus prevents capsaicin from inducing hyperaemia in the rat sciatic nerve.
    Zochodne DW; Ho LT
    Diabetologia; 1993 Jun; 36(6):493-6. PubMed ID: 8335170
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of adenosine and adenosine A2A receptor agonist on motor nerve conduction velocity and nerve blood flow in experimental diabetic neuropathy.
    Kumar S; Arun KH; Kaul CL; Sharma SS
    Neurol Res; 2005 Jan; 27(1):60-6. PubMed ID: 15829161
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nerve function and regeneration in diabetic rats: effects of ZD-7155, an AT1 receptor antagonist.
    Maxfield EK; Love A; Cotter MA; Cameron NE
    Am J Physiol; 1995 Sep; 269(3 Pt 1):E530-7. PubMed ID: 7573431
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aldose reductase inhibition with imirestat-effects on impulse conduction and insulin-stimulation of Na+/K(+)-adenosine triphosphatase activity in sciatic nerves of streptozotocin-diabetic rats.
    Carrington AL; Ettlinger CB; Calcutt NA; Tomlinson DR
    Diabetologia; 1991 Jun; 34(6):397-401. PubMed ID: 1653157
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of alpha-tocopherol on nerve conduction velocity and regeneration following a freeze lesion in immature diabetic rats.
    Love A; Cotter MA; Cameron NE
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jan; 355(1):126-30. PubMed ID: 9007852
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of streptozotocin-induced diabetic rats with AVE7688, a vasopeptidase inhibitor: effect on vascular and neural disease.
    Davidson EP; Kleinschmidt TL; Oltman CL; Lund DD; Yorek MA
    Diabetes; 2007 Feb; 56(2):355-62. PubMed ID: 17259379
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of dietary treatment with essential fatty acids on sciatic nerve conduction and activity of the Na+/K+ pump in streptozotocin-diabetic rats.
    Lockett MJ; Tomlinson DR
    Br J Pharmacol; 1992 Feb; 105(2):355-60. PubMed ID: 1313726
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ATP-sensitive K(+) channel effects on nerve function, Na(+), K(+) ATPase, and glutathione in diabetic rats.
    Hohman TC; Cotter MA; Cameron NE
    Eur J Pharmacol; 2000 Jun; 397(2-3):335-41. PubMed ID: 10844132
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Essential fatty acid diet supplementation. Effects on peripheral nerve and skeletal muscle function and capillarization in streptozocin-induced diabetic rats.
    Cameron NE; Cotter MA; Robertson S
    Diabetes; 1991 May; 40(5):532-9. PubMed ID: 2022301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.